INS and obesity due to melanocortin 4 receptor deficiency: VD is thought to enhance insulin secretion, receptor expression, and exocytosis (Maestro et al., 2000, 2002; Szymczak-Pajor et al., 2020), which may help counteract obesity-related insulin resistance and promote improved vasodilatory responses to insulin.